BOSTON PPTY

We believe Boston Properties is undervalued by more than 20% at this point and its high dividend yield just makes the stock that much more attractive.

Biogen (BIIB) has sold a laboratory and life sciences building it occupies in the middle of Cambridge, Mass.'' biotech area for $592M to Boston Properties (BXP).Biogen (BIIB) will…

https://www.investing.com/news/pro/scotiabank-upgrades-boston-properties-inc-to-sector-outperform-432SI-2897086

Boston Properties (NYSE:BXP) acquires a six-story, 271,000 square foot laboratory/life sciences property adjacent to Kendall Center, 125 Broadway from Biogen for a gross purchase price of…

Boston Properties with ticker code (BXP) have now 19 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 145 and 78 with the average target price sitting at 105.11. With the stocks previous close at 82.77 this now indicates there is a potential upside of 27.0%. The 50 day moving average now sits at 86.17 and the 200 moving average now moves to 107.76. The market cap for the company is $13,076m. You can visit the company''s website by visiting: https://www.bostonproperties.com [stock_market_widget type="chart" template="basic" color="green" assets="BXP" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $16,606m based on the market concensus. Boston Properties (NYSE:BXP) is the largest publicly-held developer and owner of Class A office properties in the United States, concentrated in five markets - Boston, Los Angeles, New York, San Francisco and Washington, DC.

Risk-reward has turned slightly positive on office REITs, a contrast from the outright negative view Mizuho analyst Vikram Malhotra had three months ago, he wrote Wednesday in a note…

Boston Properties shares have gone from overvalued to undervalued very quickly. See why we now believe BXP stock is a buy with a caveat.

Boston Properties'' fundamentals are in line with future growth prospects. At its current valuation, BXP stock is a great investment opportunity. See more here.

Boston Properties was the original owner of the 11 buildings that just changed hands, having developed them for the most part in the 1980s.

Boston Properties, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of Class A office properties in the United States, announced today that its Board of Directors declared a regular quarterly cash dividend of $0.98 per share of common stock for the period April 1, 2022 to June 30, 2022, payable on July 29, 2022 to shareholders of record as of the close of business on

Office real estate investment trust Boston Properties'' (BXP) Q4 results from Tuesday evening reflect improvement in portfolio performance. Shares of BXP edge higher by 0.01% in

Executes 1.8 Million Square Feet of Leases with a Weighted-Average Lease Term of 8.6 Years Boston Properties, Inc. (NYSE: BXP ), the largest publicly traded developer, owner, and manager of Class A office properties in the United States, announced that it executed approximately 1.8 million square feet of leases in the fourth quarter of 2021 with a weighted-average lease term of 8.6 years, bringing BXP''s total leasing activity for 2021 to approximately 5.1 million square feet. Leasing activity was widely spread across BXP''s major markets. Notable leases signed during the fourth quarter include: a 231,000 square foot lease for the entire 751 Gateway life science building in South San Francisco, California, 165,000 square feet of new leases at our new life science project at 880 Winter Street in Waltham, Massachusetts, a 120,000 … Full story available on Benzinga.com

Boston Properties (NYSE:BXP) is scheduled to announce Q4 earnings results on Tuesday, Jan. 25, after market close.

Boston Properties, Inc. (BXP) shares closed today at 1.9% below its 52 week high of $128.00, giving the company a market cap of $19B. The stock is currently up 9.1% year-to-date, up 44.5% over the past 12 months, and up 12.3% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 23.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Financials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -335.8% The company's stock price performance over the past 12 months beats the peer average by 107.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 102.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.